The present invention provides alternative forms of Compound I,
processes to reproducibly make them and methods of treating patients using them.
US8633314B2
申请人:——
公开号:US8633314B2
公开(公告)日:2014-01-21
[EN] NOVEL FORMS OF A MULTICYCLIC COMPOUND<br/>[FR] NOUVELLES FORMES D'UN COMPOSÉ MULTICYCLIQUE
申请人:CEPHALON INC
公开号:WO2011028580A1
公开(公告)日:2011-03-10
Alternative forms of Compound I, processes to reproducibly make them and methods of treating patients using them.
Compound I的替代形式,制备它们的可重复方法以及使用它们治疗患者的方法。
Multicyclic compounds and the use thereof
申请人:Cephalon, Inc.
公开号:US07122679B2
公开(公告)日:2006-10-17
The present invention is directed to novel multicyclic molecules that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of PARP, VEGFR2, and MLK3 enzymes, including, for example, neurodegenerative diseases, inflammation, ischemia, and cancer.